Perspective Therapeutics CATX
NYSE CATX
$2.98 -0.14 (-4.49%)
As of: Sep 9, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Work In Process (2011 - 2023)

Perspective Therapeutics' (CATX) quarterly Work In Process came in at $616000.0 in Q1 2023, up 73.52% year-over-year from $355000.0 in Q1 2022, and down 3.14% quarter-over-quarter from $636000.0 in Q4 2022.

Analysis

Perspective Therapeutics (CATX) Work In Process (2011 - 2023) Analysis & Trends

Perspective Therapeutics has disclosed Work In Process across 11 years of filings, most recently posting $616000.0 for Q1 2023.

  • In Q1 2023, Work In Process rose 73.52% year-over-year to $616000.0; the TTM figure through Mar 2023 stood at $616000.0 (up 73.52% YoY), while the FY2022 annual figure was $636000.0, changed N/A from the prior year.
  • Work In Process came in at $616000.0 for Q1 2023 at Perspective Therapeutics, down from $636000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $636000.0 in Q4 2022 to a low of $114000.0 in Q1 2019.
  • Average Work In Process over 5 years is $306000.0, with a median of $240000.0 recorded in 2020.
  • Year-over-year, Work In Process decreased 25.49% in 2019 and soared 129.1% in 2022.
  • Over 5 years, Work In Process stood at $166000.0 in 2019, then climbed by 26.51% to $210000.0 in 2020, then soared by 37.14% to $288000.0 in 2021, then jumped by 120.83% to $636000.0 in 2022, then declined by 3.14% to $616000.0 in 2023.
  • Per Business Quant data, the three most recent Work In Process figures were $616000.0 in Q1 2023, $636000.0 in Q4 2022, and $614000.0 in Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Perspective Therapeutics 358.23 Mn 358.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 616,000.00
Dec 31, 2022 636,000.00
Sep 30, 2022 614,000.00
Jun 30, 2022 462,000.00
Mar 31, 2022 355,000.00
Dec 31, 2021 288,000.00
Sep 30, 2021 268,000.00
Jun 30, 2021 286,000.00
Mar 31, 2021 201,000.00
Dec 31, 2020 210,000.00
Sep 30, 2020 240,000.00
Jun 30, 2020 221,000.00
Mar 31, 2020 198,000.00
Dec 31, 2019 166,000.00
Sep 30, 2019 161,000.00
Jun 30, 2019 166,000.00
Mar 31, 2019 114,000.00
Dec 31, 2018 97,000.00
Sep 30, 2018 102,000.00
Jun 30, 2018 96,000.00